$119.13
1.511.28%
At close: -
$119.61
0.480.40%
After Hours: 4:21 PM EDT
Comments
Loading...
Latest news for Neurocrine Biosciences (NASDAQ:NBIX) Stock
Neurocrine Biosciences Stock (NASDAQ: NBIX)
Categories: All
Wednesday, November 13, 2024
Tuesday, November 12, 2024
Monday, November 11, 2024
Thursday, November 07, 2024
Monday, November 04, 2024
Friday, November 01, 2024
Thursday, October 31, 2024
Wednesday, October 30, 2024
Tuesday, October 29, 2024
Thursday, October 17, 2024
Thursday, October 10, 2024
Tuesday, October 08, 2024
Friday, October 04, 2024
Monday, September 30, 2024
Monday, September 16, 2024
Friday, September 13, 2024
Thursday, September 12, 2024
Monday, September 09, 2024
Sunday, September 08, 2024
Monday, September 02, 2024
Thursday, August 29, 2024
- Neurocrine Biosciences shares are trading hig...
- Neurocrine Biosciences' Lower Dose Data Puts Its Schizophrenia Candidate In The Game, Analyst Upgrades Stock
- Cantor Fitzgerald Maintains Overweight on Neu...
- RBC Capital Maintains Sector Perform on Neuro...
- NVIDIA To Rally Over 31%? Here Are 10 Top Analyst Forecasts For Thursday
- HC Wainwright & Co. Reiterates Buy on Neurocr...
- Needham Reiterates Hold on Neurocrine Bioscie...
- Piper Sandler Upgrades Neurocrine Biosciences...
- BMO Capital Maintains Market Perform on Neuro...
Wednesday, August 28, 2024
- Nasdaq Down Over 1%; Foot Locker Shares Tumble After Q2 Results
- As Regulators Gear Up To Decide On Bristol Myers' Schizophrenia Treatment, Neurocrine Biosciences' Data Disappoints Investors
- US Stocks Mixed; JM Smucker Slashes Annual Guidance
- Neurocrine Biosciences shares are trading low...
- Neurocrine Biosciences Announced Positive Top...